University of Pittsburgh research may lead to new therapies for diabetes
Researchers at the University of Pittsburgh have developed transgenic mice that overexpress hepatocyte growth factor, leading to increased beta cell proliferation and insulin production. The study suggests that this approach may lead to new therapies for diabetes by enabling islet cells to proliferate and produce insulin more effectively.
SourceUniversity of Pittsburgh Medical Center·JournalJournal of Biological Chemistry·DateJan 14, 2000